ODI PHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.5 SEK | +0.92% |
|
+6.80% | +10.00% |
| Feb. 22 | ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
| 2023 | ODI Pharma Sells CBD Skincare Brand for SEK3 Million | MT |
| Sales 2022 | 0.31 3.41 | Sales 2023 | 0.14 1.52 | Capitalization | 83.71M 911M |
|---|---|---|---|---|---|
| Net income 2022 | -7M -76.18M | Net income 2023 | -6M -65.3M | EV / Sales 2022 | 239,089,567 x |
| Net cash position 2022 | 7.37M 80.19M | Net cash position 2023 | 6.49M 70.66M | EV / Sales 2023 | 553,698,961 x |
| P/E ratio 2022 |
-11.3
x | P/E ratio 2023 |
-12.2
x | Employees | 1 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.92% | ||
| 1 week | +6.80% | ||
| Current month | +3.77% | ||
| 1 month | +2.80% | ||
| 3 months | +10.00% | ||
| 6 months | +13.17% | ||
| Current year | +10.00% |
1 week
5.20
5.60
1 month
4.865.60
Current year
3.726.25
1 year
2.886.90
3 years
2.887.40
5 years
2.889.36
10 years
2.889.36
| Managers | Title | Age | Since |
|---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 17-12-31 |
Markus Fritzsche
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karina Kilinski
BRD | Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 17-12-31 |
| Founder | 44 | 17-12-31 | |
Karina Kilinski
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 5.5 | +0.92% | 1,450 |
| 24-04-19 | 5.45 | +4.81% | 950 |
| 24-04-18 | 5.2 | 0.00% | 1,743 |
| 24-04-17 | 5.2 | -0.95% | 8,324 |
| 24-04-16 | 5.25 | +1.94% | 1,000 |
End-of-day quote NORDIC GROWTH MARKET, April 21, 2024
More quotes
Odi Pharma AB (publ) is a Swedish-based pharmaceutical company. The Company is a manufacturer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. The Company is located in Stockholm.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Q3 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +10.00% | 7.67M | |
| +25.46% | 659B | |
| +25.38% | 557B | |
| -4.86% | 359B | |
| +16.44% | 322B | |
| +8.34% | 297B | |
| +6.13% | 215B | |
| +2.93% | 210B | |
| -7.65% | 200B | |
| -8.79% | 149B |
- Stock Market
- Equities
- ODI Stock
